These 59 statements set out what good care and treatment looks like for patients with IBD.
This one-day masterclass will be delivered by world-renowned experts exploring the management of upper GI conditions and diseases.
This position statement include suggestions for practice to ensure high quality patient experience.
Trudgill NJ, et al. Gut 2019;66:1–20. doi:10.1136/gutjnl-2018-318115
This award call is now open and applications will close at 5pm, 19th August 2019.
The briefing also includes information on the citrate content of biosimilars, feedback from patients and clinicians on the patient experience, and reference pricing.
The BSG congratulates all winners for their hard work.